The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,148
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,014
Molecular pathology of schizophrenia: more than one disease process?
Crow, T. J. (1980) · BMJ · doi:10.1136/bmj.280.6207.66 · Cited by 1,856
Brain Serotonin Content: Physiological Regulation by Plasma Neutral Amino Acids
Fernstrom, J. D., & Wurtman, R. J. (1972) · Science · doi:10.1126/science.178.4059.414 · Cited by 1,160
The current status of the dopamine hypothesis of schizophrenia
CARLSSON, A. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90012-7 · Cited by 958
The Dopamine Hypothesis of Schizophrenia: A Review*
Meltzer, H. Y., & Stahl, S. M. (1976) · Schizophrenia Bulletin · doi:10.1093/schbul/2.1.19 · Cited by 883
Self-citationBogerts, B. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790310046006 · Cited by 880
Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs
Farde, L. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250087012 · Cited by 692
Chiodo, L., & Bunney, B. (1983) · The Journal of Neuroscience · doi:10.1523/jneurosci.03-08-01607.1983 · Cited by 680
Clark, D., & White, F. J. (1987) · Synapse · doi:10.1002/syn.890010408 · Cited by 660
Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons
White, F. J., & Wang, R. Y. (1983) · Science · doi:10.1126/science.6136093 · Cited by 588
INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIA
Owen, F., Crow, T. J., Poulter, M., Cross, A. J., Longden, A., & Riley, G. J. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91740-3 · Cited by 518
Pharmacology of mesocortical dopamine neurons.
Bannon, M. J., & Roth, R. H. (1983) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06572-x · Cited by 488
Sapolsky, R. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-05-01228.1985 · Cited by 400
Increased Brain Dopamine and Dopamine Receptors in Schizophrenia
Mackay, A. V. P. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290090001001 · Cited by 397
Zur Serotonin-Hypothese der Depression*
Lesch, K., & Beckmann, H. (1990) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2007-1001206 · Cited by 391
The Role of Serotonin in Schizophrenia
Bleich, A., Brown, S.-L., Kahn, R., & van Praag, H. M. (1988) · Schizophrenia Bulletin · doi:10.1093/schbul/14.2.297 · Cited by 371
Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains
LEE, T., SEEMAN, P., TOURTELLOTTE, W. W., FARLEY, I. J., & HORNYKEIWICZ, O. (1978) · Nature · doi:10.1038/274897a0 · Cited by 351
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
Farde, L., Wiesel, F. A., Nordstr�m, A. L., & Sedvall, G. (1989) · Psychopharmacology · doi:10.1007/bf00442555 · Cited by 325
Pickar, D. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800070059008 · Cited by 318
SEEMAN, P. (1987) · Neuropsychopharmacology · doi:10.1016/0893-133x(87)90004-2 · Cited by 316
The Risks and Benefits of Clozapine versus Chlorpromazine
CLAGHORN, J., HONIGFELD, G., ABUZZAHAB, F. S., WANG, R., STEINBOOK, R., TUASON, V., & KLERMAN, G. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198712000-00002 · Cited by 301
The Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients
Meltzer, H. Y. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770030003001 · Cited by 294
Self-citationEffect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system
Andén, N.-E., & Stock, G. (1973) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1973.tb10025.x · Cited by 291
Povlsen, U. J., Norrng, U., Fog, R., & Gerlach, J. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb01268.x · Cited by 278
Meltzer, H. Y., Bastani, B., Kwon, K. Y., Ramirez, L. F., Burnett, S., & Sharpe, J. (1989) · Psychopharmacology · doi:10.1007/bf00442563 · Cited by 271
Self-citationClozapine: neuroleptic-induced EPS and tardive dyskinesia
Casey, D. E. (1989) · Psychopharmacology · doi:10.1007/bf00442559 · Cited by 251
Neurotransmitter Receptors in Frontal Cortex of Schizophrenics
Bennett, J. P. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780090013001 · Cited by 248
Lindström, L. H. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb05164.x · Cited by 246
Pickar, D., Labarca, R., Linnoila, M., Roy, A., Hommer, D., Everett, D., & Paul, S. M. (1984) · Science · doi:10.1126/science.6474162 · Cited by 246
Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics
Mita, T., Hanada, S., Nishino, N., Kuno, T., Nakai, H., Yamadori, T., Mizoi, Y., & Tanaka, C. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90332-x · Cited by 222
Bacopoulos, N. G., Hattox, S. E., & Roth, R. H. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90175-4 · Cited by 212
Positive and Negative Schizophrenic Symptoms and the Role of Dopamine
Mackay, A. V. P. (1980) · British Journal of Psychiatry · doi:10.1192/bjp.137.4.379 · Cited by 210
Plasma Homovanillic Acid as a Predictor of Response to Neuroleptics
Davila, R. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800300060007 · Cited by 203
Chiodo, L., & Bunney, B. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-09-02539.1985 · Cited by 195
Anthony Altar, C., Wasley, A. M., Neale, R. F., & Stone, G. A. (1986) · Brain Research Bulletin · doi:10.1016/0361-9230(86)90181-4 · Cited by 176
Effect of clozapine on human serum prolactin levels
(1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.12.1550 · Cited by 171
Does dopamine play a role in schizophrenia?
Carlsson, A. (1977) · Psychological Medicine · doi:10.1017/s003329170000622x · Cited by 163
Glucocorticoid-biogenic amine interactions in relation to mood and behavior
McEwen, B. S. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90234-6 · Cited by 142
Gerlach, J., Thorsen, K., & Fog, R. (1975) · Psychopharmacology · doi:10.1007/bf00421473 · Cited by 138
Kostowski, W., Gumulka, W. S., & Członkowski, A. (1972) · Brain Research · doi:10.1016/0006-8993(72)90208-9 · Cited by 125
Tritiated LSD Binding in Frontal Cortex in Schizophrenia
Whitaker, P. M. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780280046004 · Cited by 124
Effects of clozapine on cerebral catecholaminergic neurone systems
Bartholini, G., Haefely, W. E., Jalfre, M., Keller, H. H., & Pletscher, A. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb06898.x · Cited by 124
Meltzer, H. Y., Kolakowska, T., Fang, V. S., Fogg, L., Robertson, A., Lewine, R., Strahilevitz, M., & Busch, D. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790160098013 · Cited by 114
Self-citationBiochemical evidence for a transmitter role of dopamine in the rat hippocamus
Bischoff, S. F., Scatton, B., & Korf, J. (1979) · Brain Research · doi:10.1016/0006-8993(79)90056-8 · Cited by 109
B�rki, H. R., Ruch, W., & Asper, H. (1975) · Psychopharmacology · doi:10.1007/bf00421302 · Cited by 106
Abnormal Involuntary Movements in Schizophrenia
Crow, T. J., Cross, A. J., Johnstone, E. C., et al. (1982) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198210000-00010 · Cited by 105
Andersen, P. H., & Bræstrup, C. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb13094.x · Cited by 104
Blaha, C. D., & Lane, R. F. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90633-1 · Cited by 98
Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivo
Andersen, P. H., Nielsen, E. B., Grønvald, F. C., & Bræstrup, C. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90656-4 · Cited by 97
Neuropeptides and psychosomatic processes
Endröczi, E., & Fidia, F. (1983) · REAL-EOD (Library of the Hungarian Academy of Sciences and the Information Center Oriental Collection) · Cited by 91
Elsworth, J. D., Leahy, D. J., Roth, R. H., & Redmond, D. E. (1987) · Journal of Neural Transmission · doi:10.1007/bf01244639 · Cited by 91
Marder, S. R. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330099012 · Cited by 91
Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex
Matsubara, S., & Meltzer, H. Y. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90027-1 · Cited by 90
Self-citationWaldmeier, P. C., & Maître, L. (1976) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1976.tb12287.x · Cited by 85
Lowy, M. T., & Meltzer, H. Y. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90070-4 · Cited by 84
Self-citationClozapine—A serotonin antagonist?
Fink, H., Morgenstern, R., & Oelssner, W. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(84)90297-1 · Cited by 80
Rasmussen, K., & Aghajanian, G. K. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90001-2 · Cited by 76
Serotonergic component of SCH 23390: In vitro and in vivo binding analyses
McQuade, R. D., Ford, D., Duffy, R. A., et al. (1988) · Life Sciences · doi:10.1016/s0024-3205(88)80003-1 · Cited by 73
Controversies in Schizophrenia: Changes and Constancies
Gralnick, A. (1986) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1986.40.4.617 · Cited by 72
Clozapine increases rat serum prolactin levels
Meltzer, H. Y., Daniels, S., & Fang, V. S. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90482-8 · Cited by 71
Self-citationEffect of clozapine in severe tardive dyskinesia: a case report.
Meltzer, H. Y., & Luchins, D. J. (1984) · PubMed · Cited by 67
Self-citationReynolds, G. P., Rossor, M. N., & Ll, I. (1983) · PubMed · Cited by 66
A Biochemical and Neuroendocrine Study of the Serotonergic System in Depression
Koyama, T., & Meltzer, H. Y. (1986) · Springer eBooks · doi:10.1007/978-3-642-70702-5_19 · Cited by 62
Self-citationImpérato, A., & Angelucci, L. (1989) · PubMed · Cited by 60
Effect of Clozapine in Severe Tardive Dyskinesia
Meltzer, H. Y., & Luchins, D. J. (1984) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198410000-00010 · Cited by 53
Self-citationBischoff, S. F., Heinrich, M., Krauss, J., Sills, M. A., Williams, M. J., & Vassout, A. (1988) · Journal of Receptor Research · doi:10.3109/10799898809048981 · Cited by 47
Adrenocortical hormone status affects responses to dopamine receptor agonists
Faunt, J. E., & Crocker, A. D. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90720-0 · Cited by 46
Effects of clozapine on the activity of central dopaminergic and noradrenergic neurons
Souto, M., Monti, J. M., & Altier, H. (1979) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(79)90160-6 · Cited by 41
Clozapine: Mechanism of Action in Relation to its Clinical Advantages
Meltzer, H. Y. (1990) · International perspectives series : psychiatry, psychology, and neurosciences · doi:10.1007/978-1-4612-3248-3_11 · Cited by 35
Self-citationZemlan, F. P. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800120048010 · Cited by 27
Meltzer, H. Y. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90015-2 · Cited by 25
Self-citation
Cited by
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Owen, M. J., Sawa, A., & Mortensen, P. B. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01121-6 · Cited by 1,870
Grace, A. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90196-u · Cited by 1,831
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
Half a century of antipsychotics and still a central role for dopamine D2 receptors
Kapur, S., & Mamo, D. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.004 · Cited by 638
Metadata
- Authors
- Meltzer, H. Y.
- Venue
- Psychopharmacology
- Published
- 1989
- Volume
- 99
- Issue
- S1
- Pages
- S18-S27
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2000030766
- Cited by
- 602
- References
- 75
- FWCI
- 14.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.